T655-0334 Screening compound: 2-[4-(propan-2-yloxy)benzoyl]-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

T655-0334 Screening compound: 2-[4-(propan-2-yloxy)benzoyl]-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane
T655-0334 Screening compound: 2-[4-(propan-2-yloxy)benzoyl]-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound T655-0334
2-[4-(propan-2-yloxy)benzoyl]-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T655-0334

Molecular Formula

C25H28N4O4 (C25 H28 N4 O4)

Compound Name

2-[4-(propan-2-yloxy)benzoyl]-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

IUPAC name

2-[4-(propan-2-yloxy)benzoyl]-4-[5-(pyridin-4-yl)-134-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

SMILES

CC(C)Oc(cc1)ccc1C(N(C1)CC2(CCOCC2)C1c1nnc(-c2ccncc2)o1)=O

InChI

InChI=1S/C25H28N4O4/c1-17(2)32-20-5-3-19(4-6-20)24(30)29-15-21(25(16-29)9-13-31-14-10-25)23-28-27-22(33-23)18-7-11-26-12-8-18/h3-8,11-12,17,21H,9-10,13-16H2,1-2H3/t21-/m0/s1

InChI Key

LZFQNQXNDKOAFH-NRFANRHFSA-N

MDL Number (MFCD)

MFCD29002511

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.464

Distribution Coefficient, logD

2.463

Water Solubility, LogSw

-2.21

Polar Surface Area

71.424

Acid Dissociation Constant (pKa)

26.32

Base Dissociation Constant (pKb)

4.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.00

T655-0334 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Peptidomimetic Library (37031 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with T655-0334 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T655-0334?
Check Price and Availability of T655-0334, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T655-0334 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T655-0334
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T655-0334
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T655-0334 available by request